nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SLC6A2—locus ceruleus—narcolepsy	0.132	0.142	CbGeAlD
Orphenadrine—SLC6A2—autonomic nervous system—narcolepsy	0.0699	0.0755	CbGeAlD
Orphenadrine—GRIN2D—brainstem—narcolepsy	0.051	0.0551	CbGeAlD
Orphenadrine—GRIN2D—forebrain—narcolepsy	0.0492	0.0532	CbGeAlD
Orphenadrine—GRIN3A—forebrain—narcolepsy	0.0463	0.05	CbGeAlD
Orphenadrine—GRIN1—brainstem—narcolepsy	0.0455	0.0491	CbGeAlD
Orphenadrine—GRIN1—forebrain—narcolepsy	0.0439	0.0474	CbGeAlD
Orphenadrine—GRIN2D—medulla oblongata—narcolepsy	0.0356	0.0384	CbGeAlD
Orphenadrine—SCN1A—brainstem—narcolepsy	0.0306	0.0331	CbGeAlD
Orphenadrine—SCN1A—forebrain—narcolepsy	0.0296	0.032	CbGeAlD
Orphenadrine—GRIN1—midbrain—narcolepsy	0.029	0.0313	CbGeAlD
Orphenadrine—SCN10A—forebrain—narcolepsy	0.0262	0.0283	CbGeAlD
Orphenadrine—SCN9A—midbrain—narcolepsy	0.0227	0.0245	CbGeAlD
Orphenadrine—SCN1A—medulla oblongata—narcolepsy	0.0214	0.0231	CbGeAlD
Orphenadrine—GRIN2D—brain—narcolepsy	0.0204	0.0221	CbGeAlD
Orphenadrine—CHRM2—forebrain—narcolepsy	0.0202	0.0219	CbGeAlD
Orphenadrine—SCN1A—midbrain—narcolepsy	0.0195	0.0211	CbGeAlD
Orphenadrine—GRIN3A—brain—narcolepsy	0.0192	0.0208	CbGeAlD
Orphenadrine—GRIN1—brain—narcolepsy	0.0182	0.0197	CbGeAlD
Orphenadrine—SLC6A2—brainstem—narcolepsy	0.0169	0.0182	CbGeAlD
Orphenadrine—SLC6A2—forebrain—narcolepsy	0.0163	0.0176	CbGeAlD
Orphenadrine—KCNH2—forebrain—narcolepsy	0.0146	0.0158	CbGeAlD
Orphenadrine—SCN9A—brain—narcolepsy	0.0143	0.0154	CbGeAlD
Orphenadrine—SCN4A—brain—narcolepsy	0.0127	0.0138	CbGeAlD
Orphenadrine—SCN1A—brain—narcolepsy	0.0123	0.0133	CbGeAlD
Orphenadrine—SLC6A2—medulla oblongata—narcolepsy	0.0118	0.0127	CbGeAlD
Orphenadrine—HRH1—forebrain—narcolepsy	0.0117	0.0127	CbGeAlD
Orphenadrine—SCN10A—brain—narcolepsy	0.0109	0.0117	CbGeAlD
Orphenadrine—KCNH2—medulla oblongata—narcolepsy	0.0106	0.0114	CbGeAlD
Orphenadrine—SCN5A—brain—narcolepsy	0.00987	0.0107	CbGeAlD
Orphenadrine—KCNH2—midbrain—narcolepsy	0.00966	0.0104	CbGeAlD
Orphenadrine—CHRM2—brain—narcolepsy	0.0084	0.00908	CbGeAlD
Orphenadrine—CYP2E1—medulla oblongata—narcolepsy	0.00814	0.00879	CbGeAlD
Orphenadrine—HRH1—Histamine receptors—HRH3—narcolepsy	0.00679	0.151	CbGpPWpGaD
Orphenadrine—SLC6A2—brain—narcolepsy	0.00676	0.0073	CbGeAlD
Orphenadrine—KCNH2—brain—narcolepsy	0.00607	0.00656	CbGeAlD
Orphenadrine—Cyclobenzaprine—HTR2A—narcolepsy	0.00593	0.199	CrCbGaD
Orphenadrine—Fluoxetine—HTR2A—narcolepsy	0.00542	0.182	CrCbGaD
Orphenadrine—CYP2B6—brain—narcolepsy	0.00498	0.00538	CbGeAlD
Orphenadrine—HRH1—brain—narcolepsy	0.00486	0.00526	CbGeAlD
Orphenadrine—CYP2E1—brain—narcolepsy	0.00467	0.00505	CbGeAlD
Orphenadrine—Atomoxetine—HTR2A—narcolepsy	0.00348	0.117	CrCbGaD
Orphenadrine—Trimipramine—HTR2A—narcolepsy	0.00287	0.096	CrCbGaD
Orphenadrine—Promethazine—HTR2A—narcolepsy	0.00276	0.0924	CrCbGaD
Orphenadrine—Doxepin—HTR2A—narcolepsy	0.00273	0.0915	CrCbGaD
Orphenadrine—Promazine—HTR2A—narcolepsy	0.00243	0.0813	CrCbGaD
Orphenadrine—Imipramine—HTR2A—narcolepsy	0.00213	0.0712	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—narcolepsy	0.00211	0.0707	CrCbGaD
Orphenadrine—SLC6A2—Monoamine Transport—HRH3—narcolepsy	0.00184	0.041	CbGpPWpGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.00105	0.0235	CbGpPWpGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.00104	0.0231	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.000971	0.0216	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000666	0.0148	CbGpPWpGaD
Orphenadrine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.000626	0.0139	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.000616	0.0137	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.000574	0.0128	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.000574	0.0128	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000573	0.0127	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000555	0.0124	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.000555	0.0123	CbGpPWpGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000526	0.0117	CbGpPWpGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000517	0.0115	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000514	0.0114	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000514	0.0114	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000496	0.011	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.000471	0.0105	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000444	0.00988	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000444	0.00988	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000437	0.00972	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000437	0.00972	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000429	0.00954	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000422	0.00939	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000422	0.00939	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—TNF—narcolepsy	0.000415	0.00923	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000401	0.00892	CbGpPWpGaD
Orphenadrine—SLC6A2—Monoamine Transport—TNF—narcolepsy	0.000395	0.00879	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00038	0.00846	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00038	0.00846	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000374	0.00833	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000374	0.00833	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000367	0.00818	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000361	0.00804	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.000357	0.00795	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000344	0.00767	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.000344	0.00767	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000334	0.00743	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00032	0.00711	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000312	0.00695	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000307	0.00684	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TNF—narcolepsy	0.000297	0.00661	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000295	0.00657	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.00029	0.00645	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.00029	0.00645	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.000285	0.00634	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.000285	0.00634	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.00028	0.00623	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000278	0.0062	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.000275	0.00613	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000274	0.0061	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.000273	0.00609	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.00026	0.00578	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.00026	0.00578	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.000257	0.00572	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000242	0.00539	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000238	0.00531	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.000238	0.00529	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000237	0.00527	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.000234	0.00521	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000233	0.00518	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000232	0.00517	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000232	0.00517	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TNF—narcolepsy	0.000216	0.0048	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.000212	0.00472	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.000209	0.00464	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000208	0.00462	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000204	0.00455	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00018	0.00401	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000178	0.00395	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.000177	0.00395	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000172	0.00384	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000172	0.00383	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000172	0.00383	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000169	0.00377	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000169	0.00377	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000164	0.00364	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000164	0.00364	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000161	0.00358	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000161	0.00358	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.000158	0.00352	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.000158	0.00352	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.000156	0.00348	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.000156	0.00346	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.000155	0.00346	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.000149	0.00331	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.000149	0.00331	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000148	0.0033	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.000146	0.00325	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.000146	0.00325	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000144	0.0032	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.000144	0.00319	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.000141	0.00314	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00014	0.00311	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.000134	0.00299	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.000132	0.00294	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.000131	0.00291	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.000131	0.00291	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.000129	0.00287	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.000129	0.00287	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.000122	0.00272	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000121	0.00269	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00012	0.00267	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00012	0.00267	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000119	0.00264	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.000118	0.00262	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.000109	0.00242	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.000107	0.00238	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000103	0.0023	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CHKB—narcolepsy	0.000102	0.00227	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.000102	0.00227	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000102	0.00227	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.0001	0.00223	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CHKB—narcolepsy	9.98e-05	0.00222	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—narcolepsy	9.46e-05	0.00211	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TRH—narcolepsy	9.25e-05	0.00206	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TRH—narcolepsy	9.1e-05	0.00203	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	8.93e-05	0.00199	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	8.79e-05	0.00196	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	8.78e-05	0.00195	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	8.78e-05	0.00195	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—narcolepsy	8.69e-05	0.00193	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	8.64e-05	0.00192	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	8.64e-05	0.00192	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—P2RY11—narcolepsy	8.48e-05	0.00189	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—narcolepsy	8.38e-05	0.00187	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—narcolepsy	8.38e-05	0.00187	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	8.34e-05	0.00186	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRH3—narcolepsy	8.11e-05	0.00181	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	7.98e-05	0.00178	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	7.88e-05	0.00175	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	7.75e-05	0.00173	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	7.64e-05	0.0017	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	7.4e-05	0.00165	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—NPS—narcolepsy	7.4e-05	0.00165	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	7.28e-05	0.00162	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	7.28e-05	0.00162	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HCRT—narcolepsy	7.21e-05	0.0016	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HCRT—narcolepsy	7.09e-05	0.00158	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CPT1B—narcolepsy	6.93e-05	0.00154	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—narcolepsy	6.85e-05	0.00153	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CPT1B—narcolepsy	6.79e-05	0.00151	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NPS—narcolepsy	6.72e-05	0.0015	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TAC1—narcolepsy	6.72e-05	0.0015	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NPS—narcolepsy	6.61e-05	0.00147	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	6.61e-05	0.00147	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PENK—narcolepsy	6.43e-05	0.00143	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PENK—narcolepsy	6.32e-05	0.00141	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—narcolepsy	5.89e-05	0.00131	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TRH—narcolepsy	5.46e-05	0.00122	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TRH—narcolepsy	5.38e-05	0.0012	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRH3—narcolepsy	4.79e-05	0.00107	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRH3—narcolepsy	4.71e-05	0.00105	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CHKB—narcolepsy	4.63e-05	0.00103	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	4.45e-05	0.000991	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	4.38e-05	0.000975	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	4.04e-05	0.0009	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	3.98e-05	0.000885	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TAC1—narcolepsy	3.97e-05	0.000884	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NPS—narcolepsy	3.97e-05	0.000884	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NPS—narcolepsy	3.91e-05	0.000869	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TAC1—narcolepsy	3.91e-05	0.000869	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CPT1B—narcolepsy	3.15e-05	0.000701	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—narcolepsy	2.39e-05	0.000532	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	2.35e-05	0.000523	CbGpPWpGaD
